Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

70.89 +1.13 (+1.62%)
Streaming Delayed Price Updated: 3:34 PM EDT, Aug 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,272,970
Open 69.76
Bid (Size) 70.87 (2)
Ask (Size) 70.89 (1)
Prev. Close 69.76
Today's Range 69.01 - 72.12
52wk Range 62.34 - 142.00
Shares Outstanding 400,700,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Should You Buy the 3 Worst Nasdaq 100 Stocks Since the Tech Sector Selloff?
The tech sector began selling off in July as investors abandoned former higher fliers, leaving these three as the worst Nasdaq 100 stocks. 
Via InvestorPlace
DexCom, Inc. (DXCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire

Performance

YTD
-42.41%
-42.41%
1 Month
-37.85%
-37.85%
3 Month
-43.27%
-43.27%
6 Month
-40.14%
-40.14%
1 Year
-38.76%
-38.76%

More News

Read More
Should You Buy DexCom Stock After Its Post-Earnings Sell-Off?
Via The Motley Fool
Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom
Via Benzinga
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years
Via Benzinga
Demystifying DexCom: Insights From 15 Analyst Reviews
Via Benzinga
These Stocks Just Dropped by 40% and 15% -- Should You Buy the Dip?
Via The Motley Fool
Chips, Glorious Chips!
Via The Motley Fool
Is It Time to Buy July's Worst-Performing Nasdaq Stocks?
Via The Motley Fool
Hims & Hers Reports Stellar Quarter: Stock Set for a Rally
Via MarketBeat
Topics Bonds ETFs
Exposures Debt Markets
Down 40% in 1 Day, Is DexCom Stock Still a Buy?
Via The Motley Fool
Bragar Eagel & Squire, P.C. Is Investigating Nano Nuclear, Iris Energy, Ford, and DexCom and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of DexCom, Inc. (DXCM) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
Via Benzinga
Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Via MarketBeat
The Law Offices of Frank R. Cruz Announces Investigation of DexCom, Inc. (DXCM) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of DexCom, Inc. (DXCM) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
As Diabetes Battle Heats Up, Spotlight Turns To Dexcom, Abbott
Via Investor's Business Daily
DexCom, Inc. (DXCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow'
Via Benzinga
Topics Economy
Exposures Interest Rates
Top 3 Health Care Stocks That May Explode In Q3
Via Benzinga
NASDAQ: DXCM Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (NASDAQ: DXCM) Investors with Significant Losses to Contact the Firm
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
Market Momentum: Your Weekly Financial Forecast
Via Benzinga
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?
Via The Motley Fool
ON Semiconductor Posts Upbeat Earnings, Joins Oil States International, CommScope Holding And Other Big Stocks Moving Higher On Monday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.